Advertisement

Eptacog-α/factor-VIII-inhibitor-bypassing-fraction/rituximab

Various toxicities: 6 case reports

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Borg J-Y, et al. FEIBA in the treatment of acquired haemophilia A: Results from the prospective multicentre French 'FEIBA dans l'hemophilie A acquise' (FEIBHAC) registry. Haemophilia 21: 330-337, No. 3, May 2015. Available from: URL: http://doi.org/10.1111/hae.12574

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Eptacog-α/factor-VIII-inhibitor-bypassing-fraction/rituximab. Reactions Weekly 1786, 79 (2020) doi:10.1007/s40278-020-73553-1

    Download citation